Myeloproliferative neoplasms: a contemporary review
A Tefferi, A Pardanani - JAMA oncology, 2015 - jamanetwork.com
Polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF)
constitute theBCR-ABL1–negative myeloproliferative neoplasms and are characterized by …
constitute theBCR-ABL1–negative myeloproliferative neoplasms and are characterized by …
Myeloproliferative neoplasms
JL Spivak - New England Journal of Medicine, 2017 - Mass Medical Soc
Myeloproliferative Neoplasms | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Myeloproliferative neoplasms, version 3.2022, NCCN clinical practice guidelines in oncology
AT Gerds, J Gotlib, H Ali, P Bose, A Dunbar… - Journal of the National …, 2022 - jnccn.org
The classic Philadelphia chromosome–negative myeloproliferative neoplasms (MPN)
consist of myelofibrosis, polycythemia vera, and essential thrombocythemia and are a …
consist of myelofibrosis, polycythemia vera, and essential thrombocythemia and are a …
DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet …
N Gangat, D Caramazza, R Vaidya… - Journal of Clinical …, 2011 - ascopubs.org
Purpose The Dynamic International Prognostic Scoring System (DIPSS) for primary
myelofibrosis (PMF) uses five risk factors to predict survival: age older than 65 years …
myelofibrosis (PMF) uses five risk factors to predict survival: age older than 65 years …
Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet
T Barbui, G Barosi, G Birgegard, F Cervantes… - Journal of clinical …, 2011 - ascopubs.org
We present a review of critical concepts and produce recommendations on the management
of Philadelphia-negative classical myeloproliferative neoplasms, including monitoring …
of Philadelphia-negative classical myeloproliferative neoplasms, including monitoring …
Primary myelofibrosis: 2017 update on diagnosis, risk‐stratification, and management
A Tefferi - American journal of hematology, 2016 - Wiley Online Library
Disease overview: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN)
characterized by stem cell‐derived clonal myeloproliferation that is often but not always …
characterized by stem cell‐derived clonal myeloproliferation that is often but not always …
Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies
A Tefferi, W Vainchenker - Journal of clinical oncology, 2011 - ascopubs.org
To update oncologists on pathogenesis, contemporary diagnosis, risk stratification, and
treatment strategies in BCR-ABL1–negative myeloproliferative neoplasms, including …
treatment strategies in BCR-ABL1–negative myeloproliferative neoplasms, including …
Myeloproliferative neoplasms: a decade of discoveries and treatment advances
A Tefferi - American journal of hematology, 2016 - Wiley Online Library
Myeloproliferative neoplasms (MPN) are clonal stem cell diseases, first conceptualized in
1951 by William Dameshek, and historically included chronic myeloid leukemia (CML) …
1951 by William Dameshek, and historically included chronic myeloid leukemia (CML) …
One thousand patients with primary myelofibrosis: the mayo clinic experience
A Tefferi, TL Lasho, T Jimma, CM Finke, N Gangat… - Mayo Clinic …, 2012 - Elsevier
Objective To share our decades of experience with primary myelofibrosis and underscore
the importance of outcomes research studies in designing clinical trials and interpreting their …
the importance of outcomes research studies in designing clinical trials and interpreting their …
Primary myelofibrosis: 2021 update on diagnosis, risk‐stratification and management
A Tefferi - American journal of hematology, 2021 - Wiley Online Library
Abstract Disease Overview Primary myelofibrosis (PMF) is a myeloproliferative neoplasm
(MPN) characterized by stem cell‐derived clonal myeloproliferation that is often but not …
(MPN) characterized by stem cell‐derived clonal myeloproliferation that is often but not …